BACKGROUND: In airway epithelia, the kinetics of recombinant adeno-associated virus (AAV) transgene expression is slow. This has negative practical implications for research, as well as for translation into therapy. The DNA minor groove-binding agent Hoechst-33342 has been shown to enhance AAV transgene expression. In the present study, we investigated the mechanism of Hoechst-related augmentation of AAV-mediated transgene expression. METHODS: We investigated the effect of Hoechst-33342 on HT1080, COS-7, mouse and human airway epithelia transduced with different AAV serotypes encoding enhanced green fluorescent protein (eGFP). We exposed cells to increasing concentrations of Hoechst-33342 at different time points. We evaluated the effect on second-strand DNA synthesis using AAV with a self-complementary genome. We also investigated the effect on expression from transfected plasmids with and without AAV2 inverted terminal repeats (ITRs). RESULTS: We found that Hoechst-33342 significantly accelerated AAV transgene expression for all serotypes tested. Hoechst-33342 only had an effect when the treatment was given during or after transduction, even 120 days post-transduction, suggesting an effect on transgene expression regulation. Hoechst-33342 increased transgene expression when cells were transduced with a self-complementary AAV with the cytomegalovirus promoter, although there was no effect on cells transduced with conventional single-stranded AAV encoding the Rous sarcoma virus promoter. Finally, Hoechst-33342 increases gene expression from transfected plasmids regardless of the presence of AAV2 ITRs. CONCLUSIONS: Hoechst dramatically augments and accelerates AAV-mediated transgene expression in airway epithelia without altering AAV-mediated gene transfer. Hoechst activation of the cytomegalovirus promoter is seen in plasmids, although it is drastically enhanced in the context of AAV.
BACKGROUND: In airway epithelia, the kinetics of recombinant adeno-associated virus (AAV) transgene expression is slow. This has negative practical implications for research, as well as for translation into therapy. The DNA minor groove-binding agent Hoechst-33342 has been shown to enhance AAV transgene expression. In the present study, we investigated the mechanism of Hoechst-related augmentation of AAV-mediated transgene expression. METHODS: We investigated the effect of Hoechst-33342 on HT1080, COS-7, mouse and human airway epithelia transduced with different AAV serotypes encoding enhanced green fluorescent protein (eGFP). We exposed cells to increasing concentrations of Hoechst-33342 at different time points. We evaluated the effect on second-strand DNA synthesis using AAV with a self-complementary genome. We also investigated the effect on expression from transfected plasmids with and without AAV2 inverted terminal repeats (ITRs). RESULTS: We found that Hoechst-33342 significantly accelerated AAV transgene expression for all serotypes tested. Hoechst-33342 only had an effect when the treatment was given during or after transduction, even 120 days post-transduction, suggesting an effect on transgene expression regulation. Hoechst-33342 increased transgene expression when cells were transduced with a self-complementary AAV with the cytomegalovirus promoter, although there was no effect on cells transduced with conventional single-stranded AAV encoding the Rous sarcoma virus promoter. Finally, Hoechst-33342 increases gene expression from transfected plasmids regardless of the presence of AAV2 ITRs. CONCLUSIONS:Hoechst dramatically augments and accelerates AAV-mediated transgene expression in airway epithelia without altering AAV-mediated gene transfer. Hoechst activation of the cytomegalovirus promoter is seen in plasmids, although it is drastically enhanced in the context of AAV.
Authors: Philip H Karp; Thomas O Moninger; S Pary Weber; Tamara S Nesselhauf; Janice L Launspach; Joseph Zabner; Michael J Welsh Journal: Methods Mol Biol Date: 2002
Authors: David D Dickey; Katherine J D A Excoffon; James T Koerber; Jamie Bergen; Benjamin Steines; Julia Klesney-Tait; David V Schaffer; Joseph Zabner Journal: J Virol Date: 2011-06-22 Impact factor: 5.103
Authors: Ihab Hassan; Kayla S Gaines; Wesley J Hottel; Ryan M Wishy; Sara E Miller; Linda S Powers; D Thomas Rutkowski; Martha M Monick Journal: J Biol Chem Date: 2014-02-04 Impact factor: 5.157
Authors: Oliver G Chen; Steven E Mather; Christian M Brommel; Bradley A Hamilton; Annie Ehler; Raul Villacreses; Reda E Girgis; Mahmoud Abou Alaiwa; David A Stoltz; Joseph Zabner; Xiaopeng Li Journal: Cells Date: 2021-04-25 Impact factor: 7.666
Authors: Xiaopeng Li; Nathan Rossen; Patrick L Sinn; Andrew L Hornick; Benjamin R Steines; Philip H Karp; Sarah E Ernst; Ryan J Adam; Thomas O Moninger; Dana N Levasseur; Joseph Zabner Journal: PLoS One Date: 2013-12-12 Impact factor: 3.240